Ignite Creation Date:
2025-12-24 @ 9:21 PM
Ignite Modification Date:
2026-01-07 @ 3:58 PM
Study NCT ID:
NCT07037004
Status:
NOT_YET_RECRUITING
Last Update Posted:
2025-09-23
First Post:
2025-06-13
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Adding a Live Biotherapeutic Product (CBM588) to Pembrolizumab for the Treatment of Renal Cell Cancer After Surgery
Sponsor:
Organization: